MR Imaging Features of Critical Spinal Demyelinating Lesions Associated with Progressive Motor Impairment

References

1. 1.↵
   1. Reich DS,
   2. Lucchinetti CF,
   3. Calabresi PA

   . Multiple sclerosis. N Engl J Med 2018;378:169–80 doi:10.1056/NEJMra1401483 pmid:29320652

   CrossRefPubMed
2. 2.↵
   1. Mahajan KR,
   2. Nakamura K,
   3. Cohen JA, et al

   . Intrinsic and extrinsic mechanisms of thalamic pathology in multiple sclerosis. Ann Neurol 2020;88:81–92 doi:10.1002/ana.25743 pmid:32286701

   CrossRefPubMed
3. 3.↵
   1. Ontaneda D,
   2. Raza PC,
   3. Mahajan KR, et al

   ; North American Imaging in Multiple Sclerosis Cooperative (NAIMS). Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement. Brain 2021;144:1974–84 doi:10.1093/brain/awab132 pmid:33757115

   CrossRefPubMed
4. 4.↵
   1. Popescu BF,
   2. Lucchinetti CF

   . Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 2012;12:11 doi:10.1186/1471-2377-12-11 pmid:22397318

   CrossRefPubMed
5. 5.↵
   1. Preziosa P,
   2. Pagani E,
   3. Meani A, et al

   . Slowly expanding lesions predict 9-year multiple sclerosis disease progression. Neurol Neuroimmunol Neuroinflamm 2022;9:1139 doi:10.1212/NXI.0000000000001139 pmid:35105685

   CrossRefPubMed
6. 6.↵
   1. Rocca MA,
   2. Battaglini M,
   3. Benedict RH, et al

   . Brain MRI atrophy quantification in MS: From methods to clinical application. Neurology 2017;88:403–13 doi:10.1212/WNL.0000000000003542 pmid:27986875

   Abstract/FREE Full Text
7. 7.↵
   1. Barkhof F

   . The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15:239–45 doi:10.1097/00019052-200206000-00003 pmid:12045719

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Bonek R,
   2. Orlicka K,
   3. Maciejek Z

   . Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease: correlation between MRI parameters and clinical course. Neurol Neurochir Pol 2007;41:229–33 pmid:17629816

   PubMedWeb of Science
9. 9.↵
   1. Petrova N,
   2. Carassiti D,
   3. Altmann DR, et al

   . Axonal loss in the multiple sclerosis spinal cord revisited. Brain Pathol 2018;28:334–48 doi:10.1111/bpa.12516 pmid:28401686

   CrossRefPubMed
10. 10.↵
    1. Sechi E,
    2. Messina S,
    3. Keegan BM, et al

    . Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: a population-based case-control study. Mult Scler 2021;27:667–73 doi:10.1177/1352458520929192 pmid:32552535

    CrossRefPubMed
11. 11.↵
    1. Keegan BM,
    2. Kaufmann TJ,
    3. Weinshenker BG, et al

    . Progressive solitary sclerosis: gradual motor impairment from a single CNS demyelinating lesion. Neurology 2016;87:1713–19 doi:10.1212/WNL.0000000000003235 pmid:27638926

    Abstract/FREE Full Text
12. 12.↵
    1. Keegan BM,
    2. Kaufmann TJ,
    3. Weinshenker BG, et al

    . Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Mult Scler 2018;24:1445–52 doi:10.1177/1352458518781979 pmid:30047830

    CrossRefPubMed
13. 13.↵
    1. Sechi E,
    2. Keegan BM,
    3. Kaufmann TJ, et al

    . Unilateral motor progression in MS: association with a critical corticospinal tract lesion. Neurology 2019;93:e628–34 doi:10.1212/WNL.0000000000007944 pmid:31289142

    Abstract/FREE Full Text
14. 14.↵
    1. Jackson-Tarlton CS,
    2. Flanagan EP,
    3. Messina SA, et al

    . Progressive motor impairment from “critical” demyelinating lesions of the cervicomedullary junction. Mult Scler 2022;29:74–80 doi:10.1177/13524585221114438 pmid:36000479

    CrossRefPubMed
15. 15.↵
    1. Long Z,
    2. Hanson DP,
    3. Mullan BP, et al

    . Analysis of brain SPECT images coregistered with MRI in patients with epilepsy: comparison of three methods. J Neuroimaging 2018;28:307–12 doi:10.1111/jon.12496 pmid:29319202

    CrossRefPubMed
16. 16.↵
    1. Kantarci OH,
    2. Lebrun C,
    3. Siva A, et al

    . Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol 2016;79:288–94 doi:10.1002/ana.24564 pmid:26599831

    CrossRefPubMed
17. 17.↵
    1. Arrambide G,
    2. Rovira A,
    3. Sastre-Garriga J, et al

    . Spinal cord lesions: a modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler 2018;24:301–12 doi:10.1177/1352458517697830 pmid:28301287

    CrossRefPubMed
18. 18.↵
    1. Brownlee WJ,
    2. Altmann DR,
    3. Prados F, et al

    . Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. Brain 2019;142:2276–87 doi:10.1093/brain/awz156 pmid:31342055

    CrossRefPubMed
19. 19.↵
    1. Bischof A,
    2. Papinutto N,
    3. Keshavan A, et al

    ; University of California, San Francisco MS-EPIC Team. Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis. Ann Neurol 2022;91:268–81 doi:10.1002/ana.26281 pmid:34878197

    CrossRefPubMed
20. 20.↵
    1. Rocca MA,
    2. Valsasina P,
    3. Meani A, et al

    ; MAGNIMS Study Group. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS. Neurology 2019;93:e1852–66 doi:10.1212/WNL.0000000000008466 pmid:31611336

    Abstract/FREE Full Text
21. 21.↵
    1. Tsagkas C,
    2. Magon S,
    3. Gaetano L, et al

    . Spinal cord volume loss: a marker of disease progression in multiple sclerosis. Neurology 2018;91:e349–58 doi:10.1212/WNL.0000000000005853 pmid:29950437

    Abstract/FREE Full Text
22. 22.↵
    1. Zeydan B,
    2. Gu X,
    3. Atkinson EJ, et al

    . Cervical spinal cord atrophy: an early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm 2018;5:e435 doi:10.1212/NXI.0000000000000435 pmid:29435472

    Abstract/FREE Full Text
23. 23.↵
    1. Bussas M,
    2. El Husseini M,
    3. Harabacz L, et al

    . Multiple sclerosis lesions and atrophy in the spinal cord: distribution across vertebral levels and correlation with disability. Neuroimage Clin 2022;34:103006 doi:10.1016/j.nicl.2022.103006 pmid:35468568

    CrossRefPubMed
24. 24.↵
    1. Rocca MA,
    2. Preziosa P,
    3. Filippi M

    . What role should spinal cord MRI take in the future of multiple sclerosis surveillance? Expert Rev Neurother 2020;20:783–97 doi:10.1080/14737175.2020.1739524 pmid:32133874

    CrossRefPubMed
25. 25.↵
    1. Kearney H,
    2. Altmann DR,
    3. Samson RS, et al

    . Cervical cord lesion load is associated with disability independently from atrophy in MS. Neurology 2015;84:367–73 doi:10.1212/WNL.0000000000001186 pmid:25540312

    Abstract/FREE Full Text
26. 26.↵
    1. Kearney H,
    2. Miszkiel KA,
    3. Yiannakas MC, et al

    . Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis. Mult Scler 2016;22:910–20 doi:10.1177/1352458515604905 pmid:26432854

    CrossRefPubMed
27. 27.↵
    1. Eden D,
    2. Gros C,
    3. Badji A, et al

    . Spatial distribution of multiple sclerosis lesions in the cervical spinal cord. Brain 2019;142:633–46 doi:10.1093/brain/awy352 pmid:30715195

    CrossRefPubMed
28. 28.↵
    1. Kerbrat A,
    2. Gros C,
    3. Badji A, et al

    . Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability. Brain 2020;143:2089–105 doi:10.1093/brain/awaa162 pmid:32572488

    CrossRefPubMed
29. 29.↵
    1. Tintore M,
    2. Rovira A,
    3. Arrambide G, et al

    . Brainstem lesions in clinically isolated syndromes. Neurology 2010;75:1933–38 doi:10.1212/WNL.0b013e3181feb26f pmid:21098409

    Abstract/FREE Full Text
30. 30.↵
    1. Dekker I,
    2. Sombekke MH,
    3. Balk LJ, et al

    . Infratentorial and spinal cord lesions: cumulative predictors of long-term disability? Mult Scler 2020;26:1381–91 doi:10.1177/1352458519864933 pmid:31373535

    CrossRefPubMed
31. 31.↵
    1. Hindsholm AM,
    2. Cramer SP,
    3. Simonsen HJ, et al

    . Assessment of artificial intelligence automatic multiple sclerosis lesion delineation tool for clinical use. Clin Neuroradiol 2022;32:643–53 doi:10.1007/s00062-021-01089-z pmid:34542644

    CrossRefPubMed
32. 32.↵
    1. Krieger S

    . On cave paintings and shallow waters-the case for advancing spinal cord imaging in multiple sclerosis. JAMA Neurol 2022;79:9–10 doi:10.1001/jamaneurol.2021.4245 pmid:34807242

    CrossRefPubMed
33. 33.↵
    1. Kassa RM,
    2. Sechi E,
    3. Flanagan EP, et al

    . Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions. Mult Scler 2021;27:895–902 doi:10.1177/1352458520940983 pmid:32667237

    CrossRefPubMed
34. 34.↵
    1. Barakat B,
    2. Messina S,
    3. Nayak S, et al

    . Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions. Mult Scler J Exp Transl Clin 2022;8:20552173211052159 doi:10.1177/20552173211052159 pmid:35047187

    CrossRefPubMed